Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Teva Pharma shares sink as sales forecast disappoints market | Reuters
UK court backs Teva rival to AstraZeneca lung drug | Reuters
Teva Pharm to lay off a quarter of workforce, suspends dividend | Reuters
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
GSK's $235 million verdict revived against Teva, again | Reuters
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Pharmaceutical Is in Recovery - WSJ
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Generic Drugmakers Teva and Sandoz Make Major Push to Biosimilars - Hamodia.com
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Teva expects to start paying U.S. opioid settlement in 2023: CEO | Business Insurance
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
